Drug Releasing Microdiscs for Esophageal Drug Delivery
Drug Releasing Microdiscs for Esophageal Drug Delivery
批准号:
9903414
负责人:
Rachel Chevalier
金额:
$7.5万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-01 至 2022-03-31
关键词:
AddressAdrenal Cortex HormonesAffectAlginatesAmino AcidsAreaBiological AvailabilityBiomedical EngineeringBudesonideChildChildhoodChitosanChocolateClinicalControlled EnvironmentDeglutitionDevelopmentDiseaseDisease OutcomeDoseDrug Delivery SystemsDrug TargetingEosinophilic EsophagitisEpithelialEpitheliumEsophageal StenosisEsophagusExcipientsExhibitsExposure toFDA approvedFailureFailure to ThriveFilmFood AversionForce of GravityFormulationFutureGastroenterologistGastrointestinal tract structureGoalsHealthcareHigh Pressure Liquid ChromatographyHoneyHumidityIndividualIndustryInfant formulaInflammatoryIntestinesKnowledgeLeadLengthMasksMeasuresMethodologyMethodsMicrofabricationMorbidity - disease rateMucous MembraneOralPalatePathologyPatientsPatternPeristalsisPharmaceutical PreparationsPharmacologic SubstancePharmacotherapyPhysiciansPhysiologicalPhysiologyPolymersPropertySalivaSeaweedSemiconductorsShapesSiliconSiteSodiumSteroidsSurfaceSuspensionsTaste PerceptionTechniquesTemperatureTherapeuticThinnessTimeTissuesToxic effectTrainingWorkbasebiocompatible polymerbiomaterial compatibilitychronic inflammatory diseaseclinical practicecontrolled releasecostdesigneffective therapyfluticasoneimprovedin vivomanufacturing processnovelnovel therapeuticsoff-label usepediatric patientsresidenceside effectstandard of caresuccesstargeted treatmentuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY:
Eosinophilic esophagitis (EoE) is an inflammatory disease affecting children at an
increasing rate leading to failure to thrive, esophageal stricturing, and the need for long term
healthcare. Off-label use of topical steroids is the mainstay of treatment, but a high failure rate
and clinical concerns of palatability have necessitated physicians using unstudied grocery items
as excipients. The goal of this proposal is to investigate the properties of current empiric
therapies and use that knowledge to develop a microscale polymer disc (microdiscs) designed
to improve residence time of drug therapy in the esophagus. Microdiscs are designed to prolong
drug residence time in the esophagus and have controlled-release properties to increase
mucosal exposure to drug, thus delivering drug directly to the target site of EoE. The prolonged
residence time of the mucoadhesive discs will be expected to improve bioavailability which
decreases patient exposure to steroids, decreases costs, and opens new possibilities for other
pharmaceutical treatments with fewer side effects to be delivered in the same manner.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文